Ehsan Sadri MD FACS (He/Him)
[Pronunciation: essan ]
Cornea & External Disease, Glaucoma Related, Oculo-Plastic & Orbital Reconstructive Surgery
Visionary Eye Institute
Join to View Full Profile
361 Hospital RoadSuite 324Newport Beach, CA 92663
Phone+1 949-528-3608
Dr. Sadri is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Ehsan Sadri is an ophthalmologist in Newport Beach, CA and is affiliated with multiple hospitals in the area, including AHMC Anaheim Regional Medical Center, Hoag Hospital - Irvine, Hoag Memorial Hospital Presbyterian, Providence Little Company of Mary Medical Center - Torrance, MemorialCare, Long Beach Memorial Medical Center, MemorialCare, Orange Coast Memorial Medical Center, Providence Little Company of Mary Medical Center San Pedro, and St. Mary Medical Center. He received his medical degree from University of Michigan Medical School and has been in practice 17 years. He also speaks multiple languages, including Spanish, French, and Farsi. He specializes in cornea & external disease, glaucoma related, and oculo-plastic & orbital reconstructive surgery and is experienced in sjogren's syndrome, blepharoplasty, glaucoma and related disorders, ophthalmic trauma, and refractive surgery.
Education & Training
University of MarylandResidency, Ophthalmology, 2001 - 2004
Arrowhead Regional Medical CenterInternship, Transitional Year, 2000 - 2001
University of Michigan Medical SchoolClass of 2000
Certifications & Licensure
CA State Medical License 2004 - 2026
American Board of Ophthalmology Ophthalmology
Awards, Honors, & Recognition
- Fellow (FAAO) American Academy of Ophthalmology
Clinical Trials
- to Evaluate the Effectiveness and Safety of the Tixel® , VS LipiFlow® in the Treatment of Meibomian Gland Dysfunction Start of enrollment: 2022 Sep 19
- STREAMLINE®SURGICAL SYSTEM Compared to iStent Inject W® in Patients With Open-Angle Glaucoma Start of enrollment: 2022 Feb 09
- Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1% Start of enrollment: 2014 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- Durability of Treatment with a Thermomechanical Device in Meibomian Gland Dysfunction: An Observational Extension Study.Ehsan Sadri, Anthony Verachtert, Gregory D Parkhurst, Julio Echegoyen, Ifat Klein
Journal of Ocular Pharmacology and Therapeutics. 2025-04-16 - Effects of Switching to Netarsudil/Latanoprost Fixed Dose Combination from Various Latanoprost Regimens: The Phase 4 MORE Study.Jason Bacharach, Ehsan Sadri, Gagan Sawhney, Casey Kopczynski, Mohinder M Merchea
Clinical Ophthalmology. 2025-01-01 - 1 citationsEffectiveness and safety of a thermo-mechanical action device versus thermal pulsation device in the treatment of meibomian gland dysfunction.Ehsan Sadri, Anthony Verachtert, Gregory D Parkhurst, Julio Echegoyen, Ifat Klein
Journal of Cataract and Refractive Surgery. 2024-12-16
Authored Content
- The Prevalence of Demodex Blepharitis in US Eye Care Clinic Patients as Determined by Collarettes: A Pathognomonic SignJanuary 2022
Press Mentions
Multiple Surgeons to Present Data on Glaukos Technologies at 2019 American Society of Cataract and Refractive SurgeryMay 1st, 2019- Ophthalmology Technology Summit 2018 Poised to Foster New Breakthroughs and Valuable CollaborationsApril 30th, 2018
The Current Cataract Refractive LandscapeSeptember 20th, 2018
Research History
- Principle InvestigatorPresently conducting trials1995 - 2023
Professional Memberships
- Fellow
- Member
- Member
Other Languages
- Spanish, French, Farsi
Industry Relationships
- Consultant, AllerganDisclosure: Speaking
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
